Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Avexxin A/S
DescriptionSmall molecule targeting the phospholipase A2 group IVA cytosolic calcium-dependent (PLA2G4A; cPLA2-alpha) enzyme
Molecular Target Phospholipase A2 group IVA cytosolic calcium-dependent (PLA2G4A) (cPLA2-alpha)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I/II
Standard IndicationPsoriasis
Indication DetailsTreat psoriasis
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today